Sumitomo Mitsui Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Buy |
43,454
+3,896
| +10% | +$180K | 0.03% | 76 |
|
|
2025
Q1 | $2.41M | Sell |
39,558
-996
| -2% | -$60.7K | 0.04% | 72 |
|
|
2024
Q4 | $2.29M | Sell |
40,554
-207,409
| -84% | -$11.7M | 0.03% | 77 |
|
|
2024
Q3 | $12.8M | Buy |
247,963
+32,107
| +15% | +$1.66M | 0.29% | 37 |
|
|
2024
Q2 | $8.96M | Buy |
215,856
+27,402
| +15% | +$1.14M | 0.28% | 40 |
|
|
2024
Q1 | $10.2M | Buy |
188,454
+10,317
| +6% | +$559K | 0.32% | 35 |
|
|
2023
Q4 | $9.14M | Buy |
178,137
+7,617
| +4% | +$391K | 0.29% | 41 |
|
|
2023
Q3 | $9.9M | Buy |
170,520
+10,804
| +7% | +$627K | 0.32% | 35 |
|
|
2023
Q2 | $10.2M | Buy |
159,716
+16,138
| +11% | +$1.03M | 0.32% | 36 |
|
|
2023
Q1 | $9.95M | Buy |
143,578
+10,281
| +8% | +$713K | 0.31% | 34 |
|
|
2022
Q4 | $9.59M | Sell |
133,297
-3,605
| -3% | -$259K | 0.36% | 40 |
|
|
2022
Q3 | $9.73M | Sell |
136,902
-2,824
| -2% | -$201K | 0.41% | 35 |
|
|
2022
Q2 | $10.8M | Sell |
139,726
-1,208
| -0.9% | -$93K | 0.3% | 42 |
|
|
2022
Q1 | $10.3M | Buy |
140,934
+10,949
| +8% | +$800K | 0.3% | 46 |
|
|
2021
Q4 | $8.11M | Buy |
129,985
+21,364
| +20% | +$1.33M | 0.23% | 53 |
|
|
2021
Q3 | $6.43M | Buy |
108,621
+11,604
| +12% | +$687K | 0.15% | 66 |
|
|
2021
Q2 | $6.48M | Buy |
97,017
+15,083
| +18% | +$1.01M | 0.14% | 55 |
|
|
2021
Q1 | $5.17M | Buy |
81,934
+15,206
| +23% | +$960K | 0.12% | 55 |
|
|
2020
Q4 | $4.14M | Buy |
66,728
+829
| +1% | +$51.4K | 0.1% | 55 |
|
|
2020
Q3 | $3.97M | Sell |
65,899
-1,146
| -2% | -$69.1K | 0.14% | 45 |
|
|
2020
Q2 | $3.94M | Buy |
67,045
+6,843
| +11% | +$402K | 0.14% | 39 |
|
|
2020
Q1 | $3.36M | Buy |
+60,202
| New | +$3.36M | 0.17% | 35 |
|